TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Starpharma Holdings Limited ( (AU:SPL) ) has provided an update.
Starpharma Holdings Limited has announced its 2025 Annual General Meeting, scheduled for November 14, 2025, which will be held in a hybrid format allowing both in-person and remote participation. The Board recommends shareholders vote in favor of all resolutions, emphasizing the importance of shareholder engagement and participation in the company’s strategic decisions.
The most recent analyst rating on (AU:SPL) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Starpharma Holdings Limited stock, see the AU:SPL Stock Forecast page.
More about Starpharma Holdings Limited
Starpharma Holdings Limited operates in the biotechnology industry, focusing on advanced dendrimer technology to deliver meaningful patient outcomes.
YTD Price Performance: 150.0%
Average Trading Volume: 997,788
Technical Sentiment Signal: Buy
Current Market Cap: A$115M
For a thorough assessment of SPL stock, go to TipRanks’ Stock Analysis page.